Yusmiati Liau

The paper evaluates low-pass nanopore sequencing for global methylation measurement in plants, finding that higher coverage is needed for accuracy compared to vertebrates and demonstrating consistent results across sample conditions.

The paper shows that polyphenols in dried macroalgal DNA inhibit Oxford Nanopore sequencing, reducing yield and pore availability.

The paper identifies novel CYP2D6 variants and suballeles in New Zealand Māori and Pacific populations, highlighting the high frequency of CYP2D6*71.

The paper uses nanopore sequencing to identify GBA variants in a Parkinson's disease cohort, finding several risk variants and a higher dementia prevalence among carriers.

The paper develops a multiplex pharmacogenetics assay using MinION nanopore sequencing to genotype variants related to clopidogrel and warfarin, achieving >90% accuracy for most variants.

This study uses nanopore sequencing to genotype CYP2D6, accurately haplotype alleles, and detect duplications by analyzing allelic balance.